Journavx (suzetrigine) is the first new pain drug class in 20 years. Explore trial results,…
Sermo Physician Resources
Pharmaceuticals
How AI is reshaping drug development in 2026: discovery to delivery
On Sermo, physicians explore how AI is transforming drug development, from rational design to predictive…
85% of doctors say RNA-based drug lepodisiran could be a game-changer
Doctors weigh in on lepodisiran, an RNA-based drug that slashes stealth cholesterol (Lp(a)) by 94%.…